TSH receptor autoantibody immunoassay in patients with Graves' disease: Improvement of diagnostic accuracy over different generations of methods. Systematic review and meta-analysis
Tóm tắt
Từ khóa
Tài liệu tham khảo
Matthews, 2011, The role of TSH receptor antibodies in the management of Graves' disease, Eur J Intern Med, 22, 213, 10.1016/j.ejim.2011.02.006
Hamidi, 2011, Insight into thyroid-stimulating autoantibody interaction with the thyrotropin receptor N-terminus based on mutagenesis and re-evaluation of ambiguity in the region of the receptor crystal structure, Thyroid, 21, 1013, 10.1089/thy.2011.0147
Zophel, 2010, Clinical review about TRAb assay's history, Autoimmun Rev, 9, 695, 10.1016/j.autrev.2010.05.021
Adams, 1956, Abnormal responses in the assay of thyrotropin, Proc Univ Otago Med Sch, 34, 11
Meek, 1964, Characterization of the long-acting thyroid stimulator of Graves' disease, Proc Natl Acad Sci U S A, 52, 342, 10.1073/pnas.52.2.342
Lytton, 2010, Bioassays for TSH-receptor autoantibodies: an update, Autoimmun Rev, 10, 116, 10.1016/j.autrev.2010.08.018
Rees Smith, 1974, Thyroid-stimulating immunoglobulins in Graves' disease, Lancet, 2, 427, 10.1016/S0140-6736(74)91815-7
Manley, 1974, The thyrotropin-receptor in guinea-pig thyroid homogenate: interaction with the long-acting thyroid stimulator, J Endocrinol, 61, 437, 10.1677/joe.0.0610437
Iida, 1982, Detection of TSH-binding inhibitor immunoglobulins by using the Triton-solubilized receptor from human thyroid membranes, Endocrinol Jpn, 29, 227, 10.1507/endocrj1954.29.227
Davies, 1981, Autoantibodies to the human TSH receptor are not species specific, J Clin Endocrinol Metab, 52, 426, 10.1210/jcem-52-3-426
Shewring, 1982, An improved radioreceptor assay for TSH receptor antibodies, Clin Endocrinol (Oxf), 17, 409, 10.1111/j.1365-2265.1982.tb01607.x
Gupta, 2000, Thyrotropin-receptor antibodies in thyroid diseases: advances in detection techniques and clinical applications, Clin Chim Acta, 293, 1, 10.1016/S0009-8981(99)00235-1
Ilicki, 1992, Hyperthyroid Graves' disease without detectable thyrotropin receptor antibodies, J Clin Endocrinol Metab, 74, 1090
Mukuta, 1994, Immunological findings and thyroid function of untreated Graves' disease patients with undetectable TSH-binding inhibitor immunoglobulin, Clin Endocrinol (Oxf), 40, 215, 10.1111/j.1365-2265.1994.tb02471.x
Kawai, 1995, A study of untreated Graves' patients with undetectable TSH binding inhibitor immunoglobulins and the effect of antithyroid drugs, Clin Endocrinol, 43, 551, 10.1111/j.1365-2265.1995.tb02919.x
Takasu, 1997, Thyroid-stimulating antibody and TSH-binding immunoglobulins in 277 Graves' patients and in 686 normal subjects, J Clin Invest, 20, 452
Costagliola, 1999, Second generation assay for thyrotropin receptor antibodies has superior diagnostic sensitivity for Graves'disease, J Clin Endocrinol Metab, 84, 90
Bolton, 1999, Measurement of thyroid-stimulating hormone receptor autoantibodies by ELISA, Clin Chem, 45, 2285, 10.1093/clinchem/45.12.2285
Schott, 2000, Detecting TSH receptor antibodies with the recombinant TBII assay. Technical and clinical evaluation, Horm Metab Res, 32, 429, 10.1055/s-2007-978666
Bülow Pedersen, 2001, TSH receptor antibody measurement for differentiation of hyperthyroidism into Graves' disease and multinodular toxic goiter: a comparison of two competitive binding assays, Clin Endocrinol, 55, 381, 10.1046/j.1365-2265.2001.01347.x
Giovanella, 2001, Evaluation of 2nd generation radioreceptional assay for anti-TSH receptor antibodies (TRAb) in autoimmune thyroid diseases. Comparison with 1st generation anti-thyroperoxidase antibodies (AbTPO), Q J Nucl Med, 45, 115
Morgenthaler, 2002, Detection of low titre TBII in patients with Graves' disease using recombinant human TSH receptor, Clin Endocrinol, 57, 193, 10.1046/j.1365-2265.2002.01577.x
Sanders, 1999, The interaction of TSH receptor autoantibodies with 125I-labelled TSH receptor, J Clin Endocrinol Metab, 84, 3797, 10.1210/jcem.84.10.6071
Sanders, 2003, Human monoclonal thyroid stimulating autoantibody, Lancet, 362, 126, 10.1016/S0140-6736(03)13866-4
Rees Smith, 2004, A new assay for thyrotropin receptor autoantibodies, Thyroid, 14, 830, 10.1089/thy.2004.14.830
Gassner, 2007, Development of a new automated assay for thyrotropin receptor autoantibodies on the Elecsys system, Clin Chem, 53, A145
Tozzoli, 2010, Accuracy of receptor-based methods for the detection of thyrotropin-receptor antibodies: a new automated 3rd generation immunoassay presents higher analytical and clinical sensitivity for the differential diagnosis of hyperthyroidism, Autoimmun Highlights, 1, 95, 10.1007/s13317-010-0014-4
Zophel, 2010, Continuously increasing sensitivity over three generations of TSH receptor autoantibody assays, Horm Metab Res, 42, 900, 10.1055/s-0030-1267171
Kamijo, 2010, Study on cutoff value setting for differential diagnosis between Graves' disease and painless thyroiditis using the TRAb (Elecsys TRAb) measurement via the fully automated electrochemiluminescence immunoassay system, Endocr J, 57, 895, 10.1507/endocrj.K10E-199
Moher, 2009, Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement, Ann Intern Med, 151, 264, 10.7326/0003-4819-151-4-200908180-00135
Kamijo, 2003, TSH receptor antibody measurement in patients with various thyrotoxicosis and Hashimoto's thyroiditis: a comparison of two two-step assays, coated plate ELISA using porcine TSH receptor and coated tube radioassay using recombinant TSH receptor, Endocr J, 50, 113, 10.1507/endocrj.50.113
Villalta, 2004, Analytical and diagnostic accuracy of “second generation” assays for thyrotropin receptor antibodies with radioactive and chemiluminescent tracers, J Clin Pathol, 57, 378, 10.1136/jcp.2003.012294
Cardia, 2004, Evaluation of a coated tube assay for antithyrotropin receptor antibodies in patients with Graves' disease and other thyroid disorders, Thyroid, 14, 295, 10.1089/105072504323030951
Kamijo, 2005, Clinical evaluation of 3rd generation assay for thyrotropin receptor antibodies: the M22-biotin-based ELISA initiated by Smith, Endocr J, 525, 10.1507/endocrj.52.525
Mankai, 2007, Anti-thyroid-stimulating hormone receptor antibodies determined by second-generation assay, Clin Chem Lab Med, 45, 26, 10.1515/CCLM.2007.016
Yoshimura Noh, 2008, Evaluation of a new rapid and fully automated electroluminescence immunoassay for thyrotropin receptor autoantibodies, Thyroid, 18, 1157, 10.1089/thy.2008.0119
Liu, 2008, Comparison of M22-based ELISA and human TSH receptor-based luminescence assay for the measurement of thyrotropin receptor antibodies in patients with thyroid diseases, Horm Metab Res, 40, 479, 10.1055/s-2008-1077051
Massart, 2009, Intermethod variability in TSH-receptor antibody measurement: implication for the diagnosis of Graves' disease and for the follow-up of Graves' ophthalmopathy, Clin Chem, 55, 183, 10.1373/clinchem.2008.115162
Aleksic, 2009, TSH receptor antibodies for confirming the diagnosis and prediction of remission duration, in newly diagnosed Graves' disease patients, Hell J Nucl Med, 12, 146
Schott, 2009, Clinical value of the first automated TSH receptor autoantibody assay for the diagnosis of Graves' disease: an international multicentre trial, Clin Endocrinol (Oxf), 71, 566, 10.1111/j.1365-2265.2008.03512.x
Bülow Pedersen, 2010, Assays for thyroid-stimulating hormone receptor antibodies employing different specific ligands and ligand partners may have similar sensitivity and specificity but are not interchangeable, Thyroid, 10, 127, 10.1089/thy.2009.0105
Syme, 2011, Clinical performance of the Roche Cobas e411 automated assay system for thyrotropin-receptor antibodies for the diagnosis of Graves' disease, Ann Clin Biochem, 48, 471, 10.1258/acb.2011.011013
Zophel, 2010, TSH receptor antibody (TRAb) assays based on the human monoclonal antibody M22 are more sensitive than bovine TSH based assays, Horm Metab Res, 42, 65, 10.1055/s-0029-1241196
Zöphel, 2008, On specificity of 2nd generation TSH receptor autoantibody measurements, Clin Lab, 54, 243
Tozzoli, 2012, The clinical autoimmunologist and the laboratory autoimmunologist: the two sides of the coin, Autoimmun Rev, 10.1016/j.autrev.2012.02.011
Ginsberg, 1986, Clinical application of assays for thyrotropin-receptor antibodies in Graves' disease, CMAJ, 134, 1141
Baloch, 2003, Laboratory medicine practice guidelines. Laboratory support for the diagnosis and monitoring of thyroid disease, Thyroid, 13, 3, 10.1089/105072503321086962
Abalovich, 2007, Management of thyroid dysfunction during pregnancy and postpartum: an Endocrine Society clinical practice guidelines, J Clin Endocrinol Metab, 92, S1, 10.1210/jc.2007-0141
Bahn, 2011, Hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists, Thyroid, 21, 593, 10.1089/thy.2010.0417
Dasgupta, 2005, Evaluation of management of Graves' disease in district general hospital: achievement of consensus guidelines, Int J Clin Pract, 59, 1097, 10.1111/j.1742-1241.2005.00545.x
Pearce, 2011, New American Thyroid Association and American Association of Clinical Endocrinologists guidelines for thyrotoxicosis and other forms of hyperthyroidism: significant progress for the clinician and a guide to future research, Thyroid, 21, 573, 10.1089/thy.2011.0104